Centerspace (CSR) Form 4 CENTERSPACE / Mark Okey Decker Jr ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Decker Mark Okey Jr

(Last) (First) (Middle)

C/O CENTERSPACE

3100 10TH STREET SW

(Street)

MINOT ND 58701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CENTERSPACE [ CSR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
President, CEO and CIO

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest	01/01/2022		M		991	A	$0	37,555.78(1)	D
Common Shares of Beneficial Interest	01/01/2022		F		356(2)	D	$110.9	37,199.78(1)	D
Common Shares of Beneficial Interest								20	I	Child 4
Common Shares of Beneficial Interest								20	I	Child 2
Common Shares of Beneficial Interest								20	I	Child 3
Common Shares of Beneficial Interest								1,525	I	By Spouse IRA
Common Shares of Beneficial Interest								20	I	Child 1

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.0	01/01/2022		A		1,991(3)		(3)	(3)	Common Shares of Beneficial Interest	1,991	$0	1,991	D
Restricted Stock Units	$0.0	01/01/2022		M			991	01/01/2022	01/01/2022	Common Shares of Beneficial Interest	991	$0	1,982	D
Stock Options (Right to Buy)	$110.9	01/01/2022		A		13,366(4)		(4)	01/01/2032	Common Shares of Beneficial Interest	13,366	$110.9	13,366	D

Explanation of Responses:

1. The number of shares includes 88.119 shares acquired in 2021 under the Company's dividend reinvestment plan (the "DRIP"). It also include additional shares that were not previously reported due to administrative errors. The majority of these shares are time-vested RSUs that were appropriately reported as derivates on the reporting person's Forms 4 at the time of grant, but not recategorized as shares of common stock at the time of vesting. It also includes shares acquired in years prior to 2021 under the DRIP.

2. Represents shares withheld for payment of taxes in connection with the vesting of restricted stock.

3. Represents a time-based contingent right to receive 1,991 common shares of beneficial interest of Centerspace vesting over three years, in one-third increments on each anniversary of the grant date: January 1, 2023, 2024 and 2025.

4. Represents the right to purchase 13,366 common shares of beneficial interest of Centerspace, vesting over four years in one-fourth increments on each anniversary of the grant date: January 1, 2023, 2024, 2025 and 2026.

Remarks:

	Anne Olson, Attorney in Fact for Mark O. Decker, Jr.	01/04/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.